Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 Views
administrator
administrator
06/28/23

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next